Kazia Therapeutics (KZIA) Deferred Taxes (2019 - 2022)

Kazia Therapeutics' (KZIA) quarterly Deferred Taxes came in at -$89056.7 in Q4 2022, up 61.31% YoY from -$55208.0 in Q4 2021, and up 61.31% on a QoQ basis from -$230187.3 in Q4 2021.

Kazia Therapeutics (KZIA) Deferred Taxes (2019 - 2022) Analysis & Trends

Kazia Therapeutics (KZIA) has 4 years of Deferred Taxes data on file, last reported at -$89056.7 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -69.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 194.40 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -137,876.64
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2.66 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Kazia Therapeutics 4.22 Bn 4.22 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 -89,056.68
Dec 31, 2021 -230,187.29
Dec 31, 2020 -108,980.91
Dec 31, 2019 -101,862.10